Search - tctmd.com

Displaying 261 - 266 of 266

Sort: Relevancy | Date

News Industry News

Portola Pharmaceuticals Announces In Vivo Study Results Demonstrating Andexanet Alfa Significantly Reduced Bleeding and Reversed Anticoagulation Activity of Rivaroxaban While Four-Factor Prothrombin C

June 25, 2015

News Daily News

Despite No Measurable Gain in QoL, Women Still Prefer Radial for Cardiac Cath

May 15, 2015

News Daily News

HF Worsens Outcomes Following ACS, With No Benefit From Apixaban

January 28, 2015

News Conference News ESC 2012

Study Looks at Global Mortality, Stroke Rates in A-fib Patients After ER Visit

Yael L. Maxwell

August 29, 2012

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

July 12, 2012

News Daily News

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

June 03, 2011

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.